Better Therapeutics IncNASDAQ:BTTX
- LAST PRICE1.6800
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots1.5000/ 6
- Ask / Lots1.7300/ 8
- Open / Previous Close0.0000 / 1.6800
- Day Range---
- 52 Week Range
- Volume9
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BTTX |
|---|---|---|
| 09:32 ET | 2324 | 1.57 |
| 09:36 ET | 2999 | 1.58 |
| 09:45 ET | 269 | 1.55 |
| 09:50 ET | 999 | 1.56 |
| 09:52 ET | 300 | 1.57 |
| 09:54 ET | 245 | 1.57 |
| 09:59 ET | 800 | 1.58 |
| 10:06 ET | 1100 | 1.5727 |
| 10:14 ET | 829 | 1.57 |
| 10:15 ET | 1000 | 1.5841 |
| 10:17 ET | 100 | 1.58 |
| 10:26 ET | 100 | 1.58 |
| 10:37 ET | 100 | 1.58 |
| 10:44 ET | 1106 | 1.56 |
| 10:46 ET | 100 | 1.56 |
| 10:51 ET | 100 | 1.54 |
| 11:04 ET | 5210 | 1.55 |
| 11:13 ET | 3100 | 1.58 |
| 11:15 ET | 5230 | 1.55 |
| 11:18 ET | 5200 | 1.54 |
| 11:22 ET | 200 | 1.55 |
| 11:26 ET | 100 | 1.58 |
| 11:27 ET | 100 | 1.58 |
| 11:29 ET | 443 | 1.58 |
| 11:31 ET | 200 | 1.56 |
| 11:36 ET | 310 | 1.56 |
| 11:42 ET | 100 | 1.5617 |
| 11:45 ET | 100 | 1.56 |
| 11:56 ET | 1900 | 1.58 |
| 11:58 ET | 330 | 1.59 |
| 12:02 ET | 100 | 1.58 |
| 12:05 ET | 390 | 1.58 |
| 12:20 ET | 200 | 1.5999 |
| 12:34 ET | 100 | 1.59 |
| 12:45 ET | 100 | 1.575 |
| 12:50 ET | 100 | 1.56 |
| 01:06 ET | 300 | 1.58 |
| 01:14 ET | 100 | 1.58 |
| 01:17 ET | 24096 | 1.6 |
| 01:24 ET | 10901 | 1.57 |
| 01:30 ET | 100 | 1.57 |
| 01:32 ET | 5000 | 1.599 |
| 01:33 ET | 100 | 1.57 |
| 01:37 ET | 300 | 1.57 |
| 01:39 ET | 5000 | 1.599 |
| 01:42 ET | 2166 | 1.61 |
| 01:46 ET | 722 | 1.63 |
| 01:51 ET | 184 | 1.63 |
| 01:55 ET | 100 | 1.59 |
| 01:57 ET | 600 | 1.61 |
| 02:00 ET | 100 | 1.58 |
| 02:06 ET | 631 | 1.5909 |
| 02:08 ET | 1133 | 1.6099 |
| 02:09 ET | 200 | 1.57 |
| 02:22 ET | 100 | 1.585 |
| 02:24 ET | 435 | 1.5983 |
| 02:29 ET | 1396 | 1.61 |
| 02:31 ET | 136 | 1.6066 |
| 02:40 ET | 100 | 1.625 |
| 02:44 ET | 100 | 1.6399 |
| 02:47 ET | 100 | 1.625 |
| 02:51 ET | 600 | 1.63 |
| 02:56 ET | 200 | 1.625 |
| 03:00 ET | 400 | 1.64 |
| 03:05 ET | 100 | 1.625 |
| 03:07 ET | 510 | 1.6101 |
| 03:09 ET | 120 | 1.6328 |
| 03:20 ET | 800 | 1.625 |
| 03:21 ET | 100 | 1.6182 |
| 03:25 ET | 433 | 1.64 |
| 03:32 ET | 500 | 1.62 |
| 03:34 ET | 400 | 1.615 |
| 03:38 ET | 300 | 1.63 |
| 03:41 ET | 100 | 1.6261 |
| 03:43 ET | 11366 | 1.63 |
| 03:48 ET | 3126 | 1.64 |
| 03:50 ET | 1591 | 1.6401 |
| 03:52 ET | 400 | 1.6407 |
| 03:54 ET | 15269 | 1.65 |
| 03:56 ET | 14465 | 1.6698 |
| 03:57 ET | 2119 | 1.65 |
| 03:59 ET | 499 | 1.68 |
Jun 16, 2022
Better Therapeutics to Participate in Cowen 7th Annual FutureHealth Conference, from 7:30AM ET on Thursday Jun 16, 2022 by Business Wire
7:30AM ET on Thursday Jun 16, 2022 by Business Wire
Jun 9, 2022
Better Therapeutics to Participate in Cowen's Unlocking the Value of Digital Prescription Therapeutics Webinar on June 16, 2022, from 7:00AM ET on Thursday Jun 09, 2022 by Business Wire
7:00AM ET on Thursday Jun 09, 2022 by Business Wire
Jun 8, 2022
Better Therapeutics Issued US Patent for Features of Prescription Digital Therapeutics Platform; Shares Rise Pre-Bell, from 9:28AM ET on Wednesday Jun 08, 2022 by MT Newswires
9:28AM ET on Wednesday Jun 08, 2022 by MT NewswiresBRIEF-Better Therapeutics Announces Issuance Of U.S. Patent Covering Key Features Of Their Prescription Digital Therapeutics Platform, from 8:30AM ET on Wednesday Jun 08, 2022 by Thomson Reuters
8:30AM ET on Wednesday Jun 08, 2022 by Thomson ReutersBetter Therapeutics Announces Issuance of U.S. Patent Covering Key Features of Their Prescription Digital Therapeutics Platform, from 7:30AM ET on Wednesday Jun 08, 2022 by Business Wire
7:30AM ET on Wednesday Jun 08, 2022 by Business Wire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Better Therapeutics Inc | 43.7M | -0.8x | --- |
Galecto Inc | 43.7M | -0.8x | --- |
Oncolytics Biotech Inc | 56.6M | -2.7x | --- |
IN8BIO, Inc. | 43.9M | -2.5x | --- |
Neoleukin Therapeutics Inc | 42.9M | -0.9x | --- |
Gain Therapeutics Inc | 44.1M | -3.0x | --- |
Company Information
Better Therapeutics, Inc. is a prescription digital therapeutics (PDT) company. The Company is engaged in developing a novel form of cognitive-behavioral therapy to address the root causes of cardiometabolic diseases. The Company's Nutritional Cognitive Behavioral Therapy (Nutritional CBT) is a novel form of behavioral therapy for patients with type 2 diabetes and other cardiometabolic diseases. It targets the cognitive structures, behavioral routines, emotional patterns, and coping skills that underlie culturally specific eating behaviors. Its clinical development pipeline includes BT-001, BT-002, BT-003, and BT-004. The BT-001 is an investigational PDT platform that is designed to use digitally delivered Nutritional CBT to treat type 2 diabetes. The Company's platform consists of three integrated components, behavioral therapy, treatment plans, and personalization. Its behavioral therapy consists of lessons, skill-building modules, and a mechanism for goal setting.
Contact Information
- Headquarters
- 311 West 43Rd Street, 12Th FloorNEW YORK, NY, United States 10036
- Phone
- ---
- Fax
- ---
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $43.7M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 26.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.15 |
Book Value | $1.56 |
P/E Ratio | -0.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
